ADIPOQ and Alzheimer disease: In 2007, Matsuhisa et al., based on the role of adiponectin in the pathogenesis of IP, proposed to modify the HOMA-IR index in HOMA-AD (fasting glucose (mmol/l) x IRI on an empty stomach (μED/ml)/adiponectin) [14].